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Abstract
Background: Retinitis pigmentosa and other hereditary retinal degenerations (HRD) are rare genetic diseases leading to
progressive blindness. Recessive HRD are caused by mutations in more than 100 different genes. Laws of population
genetics predict that, on a purely theoretical ground, such a high number of genes should translate into an extremely
elevated frequency of unaffected carriers of mutations. In this study we estimate the proportion of these individuals within
the general population, via the analyses of data from whole-genome sequencing.
Methodology/Principal Findings: We screened complete and high-quality genome sequences from 46 control individuals
from various world populations for HRD mutations, using bioinformatic tools developed in-house. All mutations detected in
silico were validated by Sanger sequencing. We identified clear-cut, null recessive HRD mutations in 10 out of the 46
unaffected individuals analyzed (,22%).
Conclusions/Significance: Based on our data, approximately one in 4–5 individuals from the general population may be a
carrier of null mutations that are responsible for HRD. This would be the highest mutation carrier frequency so far measured
for a class of Mendelian disorders, especially considering that missenses and other forms of pathogenic changes were not
included in our assessment. Among other things, our results indicate that the risk for a consanguineous couple of
generating a child with a blinding disease is particularly high, compared to other genetic conditions.
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Introduction
Retinitis pigmentosa and allied diseases (collectively called
hereditary retinal degenerations, or HRD) are a group of
Mendelian disorders causing progressive degeneration of the
light-sensing cells of our eyes, the photoreceptors. The majority of
patients initially experience night blindness, usually during
adolescence, followed by loss of peripheral vision in any lighting
environment. At later stages, central vision can be lost as well,
leading in many cases to legal or complete blindness [1].
Although dominant and X-linked HRD forms exist and account
for many cases, most patients inherit this condition as a recessive
trait, from parents who are healthy carriers of heterozygous
mutations. Up to now, mutations in more than 100 distinct HRD
genes have been described, making this pathology one of the most
genetically heterogeneous human disease identified so far [2].
Considering that the overall prevalence of HRD is ,1 in 3,500
individuals (,1 in 6,000 for recessive HRD) [3,4], the number of
cases who can be attributed to mutations in any specific HRD
gene is therefore extremely small.
According to the laws of population genetics and to common
sense, frequent Mendelian diseases are determined by frequent
mutations that are present within the general population, while
rare diseases by rare mutations. HRD is relatively rare, however its
elevated genetic heterogeneity may result in a high frequency of
unaffected carriers of recessive mutations, if any of the many genes
involved in the disease are considered. Thanks to the wealth of
genomic information that is currently available, we have directly
assessed such a frequency.
Methods
Ethics Statement
This study involved the use of fully anonymized, publicly-
available DNA samples that were purchased from the biological
repository at the National Institute of General Medical Sciences
(NIGMS). Policies in force at NIGMS strictly prohibit the release
of any information allowing the identification of the individuals
from whom DNA samples were collected, making unnecessary
additional local IRB approval [5].
Samples
Since we needed to assess the frequency of HRD mutations per
completed, individual genomes, we refrained from using data from
on-line databases that contained partial genomic information or
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information based on uneven sequence coverage across the whole
genome (e.g. the 1,000 Genomes database). Instead, we selected a
smaller but high-quality dataset composed of genomes from 46
healthy and unrelated individuals from the NIGMS repository,
available at http://www.completegenomics.com (Feb. 2011 re-
lease, assembly software version 1.10.0.26) [6]. The cohort
analyzed included European Americans, African Americans,
Mexicans, Italians, Maasai, Yoruba, Luhyas, Chinese, Japanese,
and Gujaratis.
The NIGMS IDs of the individuals whose genome was analyzed
were: NA06985, NA06994, NA07357, NA10851, NA12004,
NA18501, NA18502, NA18504, NA18505, NA18508,
NA18517, NA18526, NA18537, NA18555, NA18558,
NA18940, NA18942, NA18947, NA18956, NA19017,
NA19020, NA19025, NA19026, NA19129, NA19648,
NA19649, NA19669, NA19670, NA19700, NA19701,
NA19703, NA19704, NA19735, NA19834, NA20502,
NA20509, NA20510, NA20511, NA20845, NA20846,
NA20847, NA20850, NA21732, NA21733, NA21737, and
NA21767.
In Silico Screening for HRD Mutations
We first compiled a list of 106 genes that were previously
associated with recessive syndromic and nonsyndromic hereditary
retinal degeneration, based on the information provided in the
Retinal Information Network (RetNet; https://sph.uth.tmc.edu/
retnet/) and the Online Mendelian Inheritance in Man (www.
ncbi.nlm.nih.gov/omim) websites (Table S1). By using simple text
parsing Perl scripts (available on request), we then identified all
DNA changes found to be present in these genes. Among these
variants, we finally selected clear-cut deleterious mutations
(nonsense, frameshift, or IVS+1, +2, 21, 22 splice site changes).
Validation and Annotation of Identified Mutations
All deleterious mutations identified in silico were validated by
direct Sanger sequencing on PCR-amplified DNA, using as
genomic template DNA that was purchased from the NIGMS
repository (http://ccr.coriell.org/nigms). The reference sequences
used for variant annotation were: NM_000327.3 and
NP_000318.1 for ROM1, NM_001142769.1 and
NP_001136241.1 or NM_001142771.1 and NP_001136243.1
for PCDH15, NM_025114.3 and NP_079390.3 for CEP290,
NM_206933.2 and NP_996816.2 for USH2A, NM_001080522.2
and NP_001073991.2 for CC2D2A, NM_000350.2 and
NP_000341.2 for ABCA4, and NM_017651.4 and NP_060121.3
for AHI1. For the remaining HRD genes, all reference sequences
enrolled in the NCBI database build 37.1 were used for
annotation.
Results
We identified clear-cut, null recessive mutations in 10 out of 46
fully-sequenced genomes from control samples, making the
cumulative frequency of unaffected carriers of pathogenic HRD
alleles ,22% (95% confidence interval = 10–34%, Table 1). All
mutations were detected in a heterozygous state, as expected, and
were verified by direct Sanger sequencing. No genome carried
more than one HRD mutation.
None of these DNA changes were previously recognized as
HRD mutations, with the exception of c.4393C.T (p.R1465X) in
CEP290. This DNA variant, detected in a Gujarati (Indian)
control, was originally described in individuals with Joubert
syndrome–related disorders from Belgium, Brazil, and the United
States [7].
Discussion
Recent sequencing of personal genomes has shown that, out of
the many non-synonymous variants identified [8], on average
every individual is an unaffected carrier of 10–20 recessive alleles
for Mendelian conditions [9,10]. Our finding experimentally that
1 in 4–5 individuals from the general world population could be a
carrier of mutations linked to hereditary blindness confirms and
extends previous theoretical estimates on HRD genetic epidemi-
ology [11]. Furthermore, our measurements represent a significant
underestimation of the real frequency, considering that no
mutations other than definite null changes were considered and
that known HRD genes account for only 50–70% of the diagnosed
cases [4]. According to the data reported in the Human Gene
Mutation Database [12] for the 106 genes analyzed, the average
ratio between null and missense mutations is 1 to 0.87. If we use
this proportion to roughly extrapolate our findings and take
missense mutations into consideration, the frequency of unaffected
carriers would be 1 in 2.5 individuals. Further extrapolation to
patients with HRD who are negative for mutations in known genes
(assumed to represent 30% of all recessive cases, based on data
from retinitis pigmentosa [4]) would lead to the even more
dramatic figure of 1 unaffected carrier in 1.7 individuals.
Table 1. Mutations in hereditary retinal degeneration genes identified in control subjects from various world populations.
NIGMS ID Ethnicity Mutated gene DNA variation Protein or splicing variation
NA10851 European American ROM1 c.493_494insA p.R165fs
NA19700 African American ROM1 c.868delC p.Q290fs
NA18526 Chinese PCDH15 c.4866_4867insGACA p.D1623fs
NA20846 Gujarati CEP290 c.7392_7393delAG p.E2465fs
NA20850 Gujarati CEP290 c.4393C.T p.R1465X
NA19020 Luhya PCDH15 c.5264_5265insGTCT p.Q1755fs
NA20509 Italian USH2A c.917_918insCAGC p.S307fs
NA18501 Yoruba CC2D2A c.1017+1G.A IVS11+1G.A
NA18504 Yoruba ABCA4 c.834delT p.S278fs
NA19129 Yoruba AHI1 c.255+1G.T IVS2+1G.T
doi:10.1371/journal.pone.0041902.t001
Frequent Blinding Mutations in the Human Genome
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The ‘‘aggregate frequency of mutations’’ of a genetically
heterogeneous Mendelian disorder can show significant disparity
with our knowledge of ‘‘disease frequency’’ or prevalence, which
may be confusing at times. This is because the aggregate frequency
is strongly influenced by the number of genes and percent of cases
that can be attributed to each gene, which are unique to every
genetic condition. Diseases like HRD, displaying high genetic
heterogeneity and a relatively even contribution for each gene,
show in general high aggregate frequency despite a low overall
prevalence [11].
Such an elevated frequency of unaffected carriers of HRD
mutations has fortunately a limited influence on the likelihood of
generating affected offspring (i.e. 1/6,000, on average), since the
chance for two unrelated parents to carry each a heterozygous
mutation in the very same gene remains low. However, it has a few
consequences for both genetic counseling and research, especially
in our age of full genome or exome sequencing. First, it is likely
that, in addition to causative mutations, other HRD alleles could
be accidentally present in patients with retinal diseases. Misinter-
pretation of such findings could complicate molecular diagnoses or
give rise to false speculations about oligogenic inheritance or
dominant effects of recessive alleles. A second consequence is that
variation databases from cohorts of healthy individuals, routinely
used as negative controls for suspected HRD variants in molecular
testing, may in fact contain true mutations.
Most important, a high frequency of HRD mutation carriers
translates into a quite increased risk for a consanguineous couple
of generating a child with a blinding disease. This phenomenon is
particularly evident in populations displaying an elevated degree of
inbreeding [13–16], for which the prevalence of hereditary
blindness is higher than the average [17]. In such a context, any
recessive mutations in any HRD genes that would be present in
both parents could be easily brought to homozygosity in the
offspring, without benefiting from the buffering effect of genetic
heterogeneity.
Supporting Information
Table S1 HRD genes screened for pathogenic muta-
tions.
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